peak cardiac effects were characterized by increases in heart rate and lv dp/dt , along with marked reduction in lv end-systolic diameter ( - 13 +/- 2 % ) , and in end-diastolic diameter ( -17 +/- 2 % ) and pressure .
C0018787
cardiac
C0225897
lv